טוען...
Chemotherapy in recurrent advanced non-small-cell lung cancer after adjuvant chemotherapy
INTRODUCTION: Despite adjuvant systemic therapy in patients with completely resected non-small-cell lung cancer (nsclc), many will subsequently relapse. We investigated treatment choices at relapse and assessed the effect of palliative platinum doublet systemic therapy in this population. METHODS: W...
שמור ב:
הוצא לאור ב: | Curr Oncol |
---|---|
Main Authors: | , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Multimed Inc.
2016
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5176371/ https://ncbi.nlm.nih.gov/pubmed/28050134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3191 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|